International Journal of Methods in Psychiatric Research

Papers
(The TQCC of International Journal of Methods in Psychiatric Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates48
Latent anxiety and depression dimensions differ amongst patients with eating disorders: A Swedish nationwide investigation34
Do we really need two sessions?: The use of a structured interview as a trauma cue reactivity paradigm28
Assessing gambling disorder using frequency‐ and time‐based response options: A Rasch analysis of the gambling disorder identification test27
Prevalence Estimation Using a Depression Screening Tool in the National Health and Nutrition Examination Survey: Comparison of Different Cutoffs21
Mental and Substance Use Disorders Prevalence Study: Background and Methods20
19
Further validation of the THINC‐it tool and extension of the normative data set in a study ofn = 10.019 typical controls19
The effectiveness and tolerability of trauma‐focused psychotherapies for psychotic symptoms: A systematic review of trauma‐focused psychotherapies19
Effect of the MyDéfi Smartphone Application on Binge Drinking Among University Students: Protocol of a Double‐Blind Multicenter Prospective National Randomized Controlled Trial Using Phosphatidylethan18
Corrigendum16
Advancing earlier transdiagnostic identification of mental health risk: A pragmatic approach at the transition to toddlerhood15
A prediction model for differential resilience to the effects of combat‐related stressors in US army soldiers14
The Future Proofing Study: Design, methods and baseline characteristics of a prospective cohort study of the mental health of Australian adolescents14
13
Measuring changes in alcohol use in Finland and Norway during the COVID‐19 pandemic: Comparison between data sources13
13
Issue Information13
CORRIGENDUM12
Correction to “Validation of the German version of the 25‐item hikikomori questionnaire 25”12
New‐onset and persistent neurological and psychiatric sequelae of COVID‐19 compared to influenza: A retrospective cohort study in a large New York City healthcare network12
Measuring cannabis quantities in online surveys: A rapid review and proposals for ways forward12
Issue Information12
The clinical & economic burden of treatment‐resistant depression in the Gulf‐Cooperation Council: The Kingdom of Saudi Arabia, Kuwait and the United Arab Emirates12
11
Cardiovascular reactivity as a measure of irritability in a transdiagnostic sample of youth: Preliminary associations11
11
Testing Bayesian models of belief updating in the context of depressive symptomatology11
Long term outcomes and causal modelling of compulsory inpatient and outpatient mental health care using Norwegian registry data: Protocol for a controversies in psychiatry research project10
Designing and implementing an experimental survey on knowledge and perceptions about alcohol warning labels10
Developing a transdiagnostic Ecological Momentary Assessment protocol for psychopathology10
10
Harmonisation of assessments of attention, social, emotional, and behaviour problems using the Child Behavior Checklist and the Strengths and Difficulties Questionnaire10
International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use Disorders9
Are effort‐based decision‐making tasks worth the effort?—A study on the associations between effort‐based decision‐making tasks and self‐report measures9
Using a daily diary for monitoring intrusive memories of trauma: A translational data synthesis study exploring convergent validity9
Sample size and precision of estimates in studies of depression screening tool accuracy: A meta‐research review of studies published in 2018–20219
New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients8
Cognitive impairment and microvascular function in end‐stage renal disease8
Phenotyping suicidal ideation and behavior: Comparing clinical characteristics and future suicide attempts between suicidal subtypes in two clinical samples8
From statistics to deep learning: Using large language models in psychiatric research8
Design of a multicenter randomized controlled trial of a post‐discharge suicide prevention intervention for high‐risk psychiatric inpatients: The Veterans Coordinated Community Care Study7
A Multinational Comparison Study of the Patient‐Reported Outcomes Measurement Information System Anxiety, Depression, and Anger Item Bank in the General Population7
Graphical methods for understanding changes in states: Understanding medication use pathways7
The Concise Health Risk Tracking ‐ Self‐Report (CHRT‐SR)—A measure of suicidal risk: Performance in adolescent outpatients7
Issue Information7
The German version of the Revised Children's Anxiety and Depression Scale—Psychometric properties and normative data for German 8‐ to 17‐year‐olds7
An 18‐month follow‐up of the Covid‐19 psychology research consortium study panel: Survey design and fieldwork procedures for Wave 67
Qatar's National Mental Health Study—The World Mental Health Qatar6
Cardiovascular risk factors in attention‐deficit/hyperactivity disorder: A family design study of Swedish conscripts6
Issue Information6
Issue Information6
Issue Information6
Modeling the normal:abnormal spectrum of early childhood internalizing behaviors: A clinical‐developmental approach for the Multidimensional Assessment Profiles Internalizing Dimensions6
The Holland Sleep Disorders Questionnaire: Factorial structure and measurement invariance in a psychiatric sample relative to the general population6
Unified Protocol for Emotional Disorders in University Students: Protocol for a Randomized Trial of Online and Blended Formats6
Association of serum brain‐derived neurotrophic factor level and early response to antipsychotic drug in first‐episode patients with schizophrenia6
0.032662868499756